|
|
|
|
LEADER |
01000cam a2200265 4500 |
001 |
1638398100 |
003 |
DE-627 |
005 |
20230428025627.0 |
007 |
tu |
008 |
950316s1994 xx ||||| 00| ||eng c |
015 |
|
|
|a 94,A43,1061
|2 dnb
|
016 |
7 |
|
|a 942132432
|2 DE-101
|
035 |
|
|
|a (DE-627)1638398100
|
035 |
|
|
|a (DE-576)044293836
|
035 |
|
|
|a (DE-599)DNB942132432
|
035 |
|
|
|a (OCoLC)75526872
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
245 |
1 |
0 |
|a Nefiracetam (DM-9384)
|b a new nootropic agent
|
263 |
|
|
|a kart. : DM 49.00
|
264 |
|
1 |
|a Aulendorf
|b ECV, Editio Cantor, Verl. für Medizin und Naturwiss.
|c 1994
|
300 |
|
|
|a S. 193 - 260
|b graph. Darst.
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
490 |
1 |
|
|a Arzneimittel-Forschung
|v 44,2a
|
500 |
|
|
|a Literaturangaben
|
583 |
1 |
|
|a Archivierung prüfen
|c 20200919
|f DE-640
|z 2
|2 pdager
|
583 |
1 |
|
|a Archivierung/Langzeitarchivierung gewährleistet
|f PEBW
|h DE-24
|2 pdager
|5 DE-289
|
655 |
|
7 |
|a Aufsatzsammlung
|0 (DE-588)4143413-4
|0 (DE-627)105605727
|0 (DE-576)209726091
|2 gnd-content
|
689 |
0 |
0 |
|D s
|0 (DE-588)4351824-2
|0 (DE-627)181233894
|0 (DE-576)211533343
|a Nefiracetam
|2 gnd
|
689 |
0 |
|
|5 (DE-627)
|
830 |
|
0 |
|a Arzneimittel-Forschung
|v 44,2a
|9 44,2a
|w (DE-627)130101516
|w (DE-576)015634078
|w (DE-600)502081-5
|x 0004-4172
|7 ns
|
912 |
|
|
|a GBV_ILN_2011
|
912 |
|
|
|a ISIL_DE-16
|
912 |
|
|
|a SYSFLAG_1
|
912 |
|
|
|a GBV_KXP
|
912 |
|
|
|a SSG-OLC-PHA
|
912 |
|
|
|a GBV_ILN_2021
|
912 |
|
|
|a ISIL_DE-289
|
951 |
|
|
|a BO
|
980 |
|
|
|2 2011
|1 01
|x DE-16
|b 3297790296
|c 00
|f --%%--
|d ZSN 155 C : 44,2A (44,2)
|e --%%--
|j --%%--
|y l01
|z 16-03-95
|
980 |
|
|
|2 2021
|1 01
|x DE-289
|b 3297790385
|c 00
|f Z 01
|d 305,44,2a
|e --%%--
|j --%%--
|y l01
|z 26-01-05
|